World Journal of Otorhinolaryngology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Number of total visits: 253140

Number of visits today: 26

Number of downloads: 76696

MEMBERSHIP

BPG JOURNALS

Cited by in F6Publishing

For:	Guo J, Cheng M, Liu P, Cao D, Luo J, Wan Y, Fang Y, Jin Y, Xie SS, Liu J. A multi-target directed ligands strategy for the treatment of Alzheimer's disease: Dimethyl fumarate plus Tranilast modified Dithiocarbate as AChE inhibitor and Nrf2 activator. Eur J Med Chem 2022;242:114630. [PMID: 35987018 DOI: 10.1016/j.ejmech.2022.114630] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]

For:

Guo J, Cheng M, Liu P, Cao D, Luo J, Wan Y, Fang Y, Jin Y, Xie SS, Liu J. A multi-target directed ligands strategy for the treatment of Alzheimer's disease: Dimethyl fumarate plus Tranilast modified Dithiocarbate as AChE inhibitor and Nrf2 activator. Eur J Med Chem 2022;242:114630. [PMID: 35987018 DOI: 10.1016/j.ejmech.2022.114630] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]

Number	Citing Articles
1	Amoroso R, Maccallini C, Bellezza I. Activators of Nrf2 to Counteract Neurodegenerative Diseases. Antioxidants (Basel) 2023;12:778. [PMID: 36979026 DOI: 10.3390/antiox12030778] [Reference Citation Analysis]
2	Vrabec R, Blunden G, Cahlíková L. Natural Alkaloids as Multi-Target Compounds towards Factors Implicated in Alzheimer's Disease. Int J Mol Sci 2023;24. [PMID: 36901826 DOI: 10.3390/ijms24054399] [Reference Citation Analysis]
3	Liu X, Yu C, Yao Y, Lai H, Ye X, Xu J, Guo J, Xiao X, Lin C, Huang Z, Lin J, Yu C, Zha D. Novel neuroprotective pyromeconic acid derivatives with concurrent anti-Aβ deposition, anti-inflammatory, and anti-oxidation properties for treatment of Alzheimer's disease. Eur J Med Chem 2023;248:115120. [PMID: 36682173 DOI: 10.1016/j.ejmech.2023.115120] [Reference Citation Analysis]
4	Cheong SL, Tiew JK, Fong YH, Leong HW, Chan YM, Chan ZL, Kong EWJ. Current Pharmacotherapy and Multi-Target Approaches for Alzheimer's Disease. Pharmaceuticals (Basel) 2022;15. [PMID: 36559010 DOI: 10.3390/ph15121560] [Reference Citation Analysis]
5	Li X, Li T, Zhang P, Li X, Lu L, Sun Y, Zhang B, Allen S, White L, Phillips J, Zhu Z, Yao H, Xu J. Discovery of novel hybrids containing clioquinol−1-benzyl-1,2,3,6-tetrahydropyridine as multi-target-directed ligands (MTDLs) against Alzheimer's disease. European Journal of Medicinal Chemistry 2022;244:114841. [DOI: 10.1016/j.ejmech.2022.114841] [Reference Citation Analysis]
6	Du H, Huang Z, Zhou X, Kuang X, Long C, Tang H, Zeng J, Huang H, Liu H, Zhu B, Fu L, Hu K, Lin S, Wang H, Zhang Q, Yan J, Shen H. Oxidative stress-induced lncRNA CYLD-AS1 promotes RPE inflammation via Nrf2/miR-134-5p/NF-κB signaling pathway. FASEB J 2022;36:e22577. [PMID: 36165267 DOI: 10.1096/fj.202200887R] [Reference Citation Analysis]